Difference between revisions of "Part:BBa K5124001"

Revision as of 11:59, 1 October 2024

LwCas13a codon opt

Usage and Biology

The Exeter iGEM 2024 team are designing a rapid detection system for Bovine Tuberculosis (bTB) using CRISPR-Cas detection systems. The literature suggests that bTB infection in cattle can be detected by nucleic acid biomarkers in both blood [1] and tissue samples [2]. Therefore, there was potential to develop tests looking for both DNA and RNA biomarkers in infected cattle.

This Cas13a enzyme is from Leptotrichia wadei and was chosen for our project as it was used in the SHERLOCK detection system developed by Gootenberg et al. 2017 and later Kellner et al. 2019 [3, 4]. Although RNA guided, in contrast to the widely known Streptococcus pyogenes Cas9, LwCas13a recognises and specifically cleaves RNA, therefore we are developing an RNA detection system with this enzyme.

Originally named C2c2 (class 2 candidate 2), Cas13a was first identified in Leptotrichia shahii [5]. It is part of a class II, type VI CRISPR system that does not use a trans-activating (tracrRNA) but instead the Cas13a enzyme itself can cleave pre-crRNA [6]. Each mature crRNA consists of a consensus repeat sequence and a 20-nucleotide spacer sequence. The repeat sequence BBa_K5124012 folds into a hairpin loop that is recognised and bound by Cas13a. The spacer sequence is complimentary to a sequence of viral RNA that the bacterium has previously been exposed to.

Characterisation

The coding sequence for LwCas13a was taken from the plasmid pC029-Lw2Cas13a from Leptotrichia wadei F0279 (Addgene plasmid #91919) [7] and codon optimised for expression in E. coli using the IDT tool. Any restriction enzyme sites that would prevent compatibility with BioBrick and Type IIs cloning were removed. A 6xHis tag and TEV protease cleavage site was added at the N-terminal, Type IIS cloning prefix and suffixes were added and the complete sequence was synthesised as a g-Block by IDT. This was cloned into a medium copy plasmid (origin of replication from pBR322 [8]) carrying an ampicillin selection marker with a composite part comprising the T7 promoter, lac operator and the RBS from bacteriophage T7 gene 10 (BBa_K5124042) and the transcription terminator from bacteriophage T7 RNA polymerase (BBa_K395601)

The LwCas13a expression plasmid was transformed into E. coli BL21(DE3) (Novagen) and protein expression was induced by autoinduction media [9]. The enzyme was purified via Ni-affinity and size exclusion chromatography. Please see our Wiki for the detailed protocol (Wiki experiments).

Results

We used this Cas13a sample in our test of the overall system, and got a positive result for some of the targets, and a negative result for the negative controls, meaning the test worked! Purity could still be improved for a real life test. Cas13a bands on western blots look clearer and show lower levels of impurities than our first purification. Using Qubit fluorometer 2.0, we measured the concentration of the protein samples and the first purified Cas13a sample was 612 µg/ml whilst last purified Cas13a sample was 183 µg/ml. The significant decrease in the concentration of the samples, along with the SDS-PAGE results demonstrates that although protein concentration in the sample decreased, purity increased.

We can tell the Cas13a system worked because we got positive results when the Cas13a, sgRNA, target and probe were added together (as shown in the graph above), but also because we had negative controls that caused no reaction. These were:
The system missing one of the 4 parts showing all parts are necessary.
The system with the wrong target showing that the system only activates with the correct RNA sequence.
The system with the spacer FOSB which folded incorrectly, showing the testing for the folding of sequences was necessary.

References

1. McLoughlin KE, Correia CN, Browne JA, Magee DA, Nalpas NC, Rue-Albrecht K, et al. RNA-Seq Transcriptome Analysis of Peripheral Blood From Cattle Infected With Mycobacterium bovis Across an Experimental Time Course. Frontiers in Veterinary Science. 2021; 8:662002.

2. Taylor GM, Worth DR, Palmer S, Jahans K, Hewinson RG. Rapid detection of Mycobacterium bovis DNA in cattle lymph nodes with visible lesions using PCR. BMC Vet Res. 2007 Jun 13; 3:12.

3. Gootenberg JS, Abudayyeh OO, Lee JW, Essletzbichler P, Dy AJ, Joung J, et al. Nucleic acid detection with CRISPR-Cas13a/C2c2. Science. 2017 Apr 28; 356(6336):438-42.

4. Kellner MJ, Koob JG, Gootenberg JS, Abudayyeh OO, Zhang F. SHERLOCK: nucleic acid detection with CRISPR nucleases. Nat Protoc. 2019 Oct; 14(10):2986-3012.

5. Shmakov S, Abudayyeh OO, Makarova KS, Wolf YI, Gootenberg JS, Semenova E, et al. Discovery and Functional Characterization of Diverse Class 2 CRISPR-Cas Systems. Mol Cell. 2015 Nov 5; 60(3):385-97.

6. East-Seletsky A, O'Connell MR, Knight SC, Burstein D, Cate JH, Tjian R, et al. Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection. Nature. 2016 Oct 13; 538(7624):270-3.

7. Abudayyeh OO, Gootenberg JS, Essletzbichler P, Han S, Joung J, Belanto JJ, et al. RNA targeting with CRISPR-Cas13. Nature. 2017 Oct 12; 550(7675):280-4.

8. Sutcliffe JG. Complete nucleotide sequence of the Escherichia coli plasmid pBR322. Cold Spring Harb Symp Quant Biol. 1979; 43 Pt 1:77-90.

9. Studier FW. Protein production by auto-induction in high density shaking cultures. Protein Expr Purif. 2005 May; 41(1):207-34.

Sequence and Features